Clinical trials in lung cancer surgery and research cooperation.

摘要: Background: With China having an increasingly huge burden of lung cancers, the number Chinese studies was second largest all over world. Methods: We used advanced search option available on ClinicalTrials.gov to review clinical trials regarding surgical issues. In drop down menus, we chose “all studies” for recruitment status and “interventional” study type reported until Aug, 2013 website were included. Results: Clinical cancer surgeries (658 records) mainly aim at procedures (neo)adjuvant studies, among which phase III account 15.5%. Only 34.9% (230 completed, 43 presented their results . The median time completion (MTC) procedure is 9.4 years. MTCs neo-adjuvant adjuvant have not been reached, but definitely are longer than 10 comparison, MTC in first-line treatment only 4.3 years. Comments: summarized characteristics these using real-world case examples. Our analyses reveal that it critically needed regulatory authorities, trial sponsors, collaborative research groups, academic institutions work together build up infrastructure cooperation with a component. 2007, national group, Thoracic Oncology Group (CTONG), established. CTONG network researchers, physicians health-care professionals public throughout currently has growing membership 25 hospitals. A CTONG-sponsored (CTONG1104) discussed illustrate our experience trials. summary, imperative investigators collaborate cooperative order expedite applications therapies from researches treatment. Since multidisciplinary, current should multiple combinations while retaining focus, be carried out systematically extensive monitoring coordinating systems.